| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $467.6M | +29.7% |
| Cost of Revenue | $201.8M | +21.8% |
| Gross Profit | $265.8M | +36.5% |
| R&D Expense | $208.6M | -7.4% |
| SG&A Expense | $159.6M | +15.4% |
| Operating Income | -$126.9M | +43.2% |
| Pre-tax Income | -$140.9M | +41.0% |
| Income Tax | -$4.2M | -165.0% |
| Net Income | -$136.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.8M | -38.6% |
| Accounts Receivable | $46.1M | -46.0% |
| Inventory | $78.1M | -13.5% |
| Current Assets | $248.8M | -23.1% |
| Total Assets | $796.4M | -7.9% |
| Current Liabilities | $186.0M | +2.0% |
| Long-term Debt | $123.6M | +0.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.6M | +143.3% |
| Capital Expenditures | $12.6M | -28.7% |
| Investing Cash Flow | -$19.8M | +15.6% |
| Financing Cash Flow | -$18.7M | -1550.9% |
| Free Cash Flow | $7.0M | +111.1% |
| +44.3% |
| EPS (Basic) | -$1.58 | +46.1% |
| EPS (Diluted) | -$1.58 | +46.1% |
| Total Liabilities |
| $344.5M |
| -1.1% |
| Stockholders' Equity | $451.9M | -12.5% |